Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study
Diabetes Care 2023 May 01;46(5)e101-e102, JI Martínez-Montoro, MJ Picón-César, VJ Simón-Frapolli, JL Pinzón-Martín, J García-Alemán, M Durán-Martínez, FJ TinahonesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.